Calculators

401k Retirement Calculator Mortgage Calculator

New

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Abattis Bioceuticals Corp (ATTBF)

OTHER OTC:ATTBF

ATTBF

Abattis Bioceuticals

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Abattis Bioceuticals (ATTBF) Income Statement

172 Followers

Abattis Bioceuticals Income Statement

Last quarter (Q ), Abattis Bioceuticals's total revenue was C$723.18K, an increase of 29190.60% from the same quarter last year. In Q, Abattis Bioceuticals's net income was C$-907.06K. See Abattis Bioceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 19	Sep 18	Sep 17	Sep 16	Sep 15
Total Revenue	C$ 853.79K	C$ 356.88K	C$ 8.37K	C$ 0.00	C$ 0.00	C$ 91.94K
Cost of Revenue	C$ 115.54K	C$ 115.54K	C$ 1.89K	-	C$ 0.00	C$ 29.32K
Gross Profit	C$ 737.61K	C$ 241.34K	C$ 6.48K	-	C$ 0.00	C$ 62.62K
Operating Expense	C$ 4.79M	C$ 4.26M	C$ 15.84M	C$ 6.36M	C$ 2.31M	C$ 3.14M
Operating Income	C$ -2.46M	C$ 253.02K	C$ 15.24K	C$ -6.36M	C$ -2.31M	C$ -3.08M
Net Non Operating Interest Income Expense	C$ 6.44K	C$ 15.90K	C$ -5.19M	C$ -6.48K	C$ -34.28K	C$ -41.53K
Other Income Expense	C$ 2.55M	C$ -6.02K	C$ 56.50M	C$ -1.56M	C$ -72.85K	C$ -2.87M
Pretax Income	C$ -3.74M	C$ -3.74M	C$ -77.50M	C$ -7.93M	C$ -2.41M	C$ -5.99M
Tax Provision	-	-	-	-	C$ 0.00	C$ -419.29K
Earnings From Equity Interest Net Of Tax	-	-	C$ -870.32K	-	-	-
Net Income Common Stockholders	C$ -3.04M	C$ -3.04M	C$ -78.01M	C$ -7.63M	C$ -2.34M	C$ -4.47M
Basic EPS	C$ -0.01	C$ -0.01	C$ -0.24	C$ -0.05	C$ -0.03	C$ -0.06
Diluted EPS	C$ -0.01	C$ -0.01	C$ -0.24	C$ -0.05	C$ -0.03	C$ -0.06
Basic Average Shares	C$ 1.88B	C$ 470.49M	C$ 322.64M	C$ 148.67M	C$ 95.00M	C$ 68.82M
Diluted Average Shares	C$ 1.88B	C$ 470.49M	C$ 322.64M	C$ 148.67M	C$ 95.00M	C$ 68.82M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 1.04M	C$ -4.37M	C$ -15.84M	C$ 6.36M	C$ 2.31M	C$ 3.17M
Net Income From Continuing And Discontinued Operation	C$ -3.74M	C$ -3.74M	C$ -77.50M	C$ -7.63M	C$ -2.34M	C$ -4.47M
Normalized Income	C$ -4.47M	C$ -2.41M	C$ -14.10M	C$ -5.93M	C$ -2.27M	C$ -2.05M
Interest Expense	C$ 2.35K	-	-	C$ 6.48K	C$ 29.85K	C$ 36.42K
EBIT	C$ -3.70M	C$ -3.70M	C$ -73.17M	C$ -7.92M	C$ -2.38M	C$ -5.96M
EBITDA	C$ -3.59M	C$ -3.59M	C$ -73.14M	C$ -7.80M	C$ -2.25M	C$ -5.77M

Currency in CAD

Abattis Bioceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing